Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Jul 2026 for Armata Pharmaceuticals, Inc., €52k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Deborah Birx: trading record in brief
Deborah Birx (board member) discloses dealings in 2 companies, chiefly Armata Pharmaceuticals, Inc. and Innoviva, Inc. In total, 9 filings cover trades dated from 14 May 2021 to 10 July 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 14 July 2026, the filings show a share grant worth €52k in Armata Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Deborah Birx
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
14,041 shares@ US$4.260.041% mcap29.0% of flowCommon StockSEC:0001104659-26-083516:0
4,919 shares@ US$10.5435.1% of flowCommon StockSEC:0001104659-26-029711:0
13,637 shares@ US$2.2731.8% of flowCommon StockSEC:0001104659-25-067746:0
22,925 shares@ US$2.68100.0% of flowCommon StockSEC:0001104659-25-039417:0
60,000 shares0Common StockSEC:0001104659-24-035723:0
200,000 shares0Common StockSEC:0001104659-23-129365:0
16,495 shares0Common StockSEC:0001104659-23-064214:0
12,647 shares0Common StockSEC:0001567619-22-009046:0
17,482 shares0Common StockSEC:0001567619-21-010826:0
9 of 9 declarations
